Drug pricing review board orders manufacturer to lower prices on kidney medicine
Canada’s drug pricing watchdog has ordered a pharmaceutical company to lower its prices on a medicine used to treat a genetic disorder that harms kidney function. ...To view the full article, register now.
Already a subscriber? Click here to view full article